NDC Package 0002-7722-11 Omvoh

Mirikizumab-mrkz Kit Subcutaneous; Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0002-7722-11
Package Description:
1 KIT in 1 CARTON * 1 mL in 1 SYRINGE (0002-8870-01) * 2 mL in 1 SYRINGE (0002-1442-01)
Product Code:
Proprietary Name:
Omvoh
Non-Proprietary Name:
Mirikizumab-mrkz
Usage Information:
OMVOH is contraindicated in patients with a history of serious hypersensitivity reaction to mirikizumab-mrkz or any of the excipients [see Warnings and Precautions (5.1)].
11-Digit NDC Billing Format:
00002772211
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Eli Lilly And Company
Dosage Form:
Kit - A packaged collection of related material.
Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Sample Package:
No
FDA Application Number:
BLA761279
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
01-15-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 0002-7722-11 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
00002772211J2267Inj, mirikizumab-mrkz, 1 mg1 MG31300300

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0002-7722-11?

The NDC Packaged Code 0002-7722-11 is assigned to a package of 1 kit in 1 carton * 1 ml in 1 syringe (0002-8870-01) * 2 ml in 1 syringe (0002-1442-01) of Omvoh, a human prescription drug labeled by Eli Lilly And Company. The product's dosage form is kit and is administered via subcutaneous; subcutaneous form.

Is NDC 0002-7722 included in the NDC Directory?

Yes, Omvoh with product code 0002-7722 is active and included in the NDC Directory. The product was first marketed by Eli Lilly And Company on January 15, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0002-7722-11?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 0002-7722-11?

The 11-digit format is 00002772211. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20002-7722-115-4-200002-7722-11